Interest Expense of Travere Therapeutics, Inc. from 31 Aug 2010 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Travere Therapeutics, Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Aug 2010 to 31 Mar 2024.
  • Travere Therapeutics, Inc. Interest Expense for the quarter ending 31 Mar 2024 was $2,800,000, a 3.4% decline year-over-year.
  • Travere Therapeutics, Inc. Interest Expense for the twelve months ending 31 Mar 2024 was $11,200,000, a 1.8% decline year-over-year.
  • Travere Therapeutics, Inc. annual Interest Expense for 2023 was $11,300,000, a 2.7% increase from 2022.
  • Travere Therapeutics, Inc. annual Interest Expense for 2022 was $11,000,000, a 44% decline from 2021.
  • Travere Therapeutics, Inc. annual Interest Expense for 2021 was $19,700,000, a 3.1% increase from 2020.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Travere Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $11,200,000 $2,800,000 -$100,000 -3.4% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $11,300,000 $2,700,000 $0 0% 01 Oct 2023 31 Dec 2023 10-K 20 Feb 2024 2023 FY
Q3 2023 $11,300,000 $2,800,000 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $11,300,000 $2,900,000 -$100,000 -3.3% 01 Apr 2023 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $11,400,000 $2,900,000 +$400,000 +16% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q4 2022 $11,000,000 $2,700,000 01 Oct 2022 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $2,800,000 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $3,000,000 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $2,500,000 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2014 $7,400,000 $6,978,937 +$6,937,369 +16689% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $462,631 $2,600,000 +$2,600,000 01 Jul 2014 30 Sep 2014 10-K 11 Mar 2015 2014 FY
Q2 2014 $2,137,369 $2,178,937 -$2,178,932 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 $41,563 $0 +$41,563 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 $0 $41,568 +$41,068 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q3 2013 $41,068 $0 -$26,761 -100% 01 Jul 2013 30 Sep 2013 10-K 11 Mar 2015 2014 FY
Q2 2013 $14,307 $5* +$26,466 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $40,773 $41,563 -$24,236 -140% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q4 2012 $16,537 $500* $0 01 Sep 2012 30 Nov 2012 10-Q 06 Mar 2013 2012 Q3
Q3 2012 $16,537 $26,761 +$26,261 01 Jul 2012 30 Sep 2012 10-Q/A 09 Jul 2015 2013 Q3
Q2 2012 $42,798 $26,471 -$26,971 01 Apr 2012 30 Jun 2012 10-Q 16 Sep 2013 2013 Q2
Q1 2012 $15,827 $17,327 01 Jan 2012 31 Mar 2012 10-Q/A 16 Sep 2013 2013 Q1
Q4 2011 $500* 01 Sep 2011 30 Nov 2011 10-Q 06 Mar 2013 2012 Q3
Q3 2011 $500* -$3,126 01 Jun 2011 31 Aug 2011 10-Q 10 Oct 2012 2012 Q2
Q2 2011 $500* 01 Mar 2011 31 May 2011 10-Q 08 Aug 2012 2012 Q1
Q3 2010 $3,626* 01 Jun 2010 31 Aug 2010 10-Q/A 06 Jun 2012 2011 Q2

Travere Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $11,300,000 +$300,000 +2.7% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2024 2023 FY
2022 $11,000,000 -$8,700,000 -44% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2024 2023 FY
2021 $19,700,000 +$600,000 +3.1% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $19,100,000 +$300,000 +1.6% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $18,800,000 +$8,990,000 +92% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $9,810,000 +$5,388,000 +122% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $4,422,000 -$312,000 -6.6% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $4,734,000 -$2,966,000 -39% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $7,700,000 +$300,000 +4.1% 01 Jan 2015 31 Dec 2015 10-K 06 Jul 2018 2017 FY
2014 $7,400,000 +$7,400,000 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $0 -$84,087 -100% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $84,087 01 Jan 2012 31 Dec 2012 10-K/A 09 Jul 2015 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.